ZBTB34 and adrenal cortex carcinoma: Furthermore, lowly expressed ZBTB34 was associated with the poor prognosis of KIRC whereas highly expressed ZBTB34 was associated with the poor prognosis of ACC, BRAC, COAD, and LIHC malignancies.